Publications

(Displaying in Reverse Chronological Order)

1981
Vats P, Bhushan B, Chakarborti AK and Banerjee UC. Separation and identification of enzymatically prepared dephosphorylated products of myo-inositolhexakisphosphate using LC-MS Journal of Separation Science 2008, 22, 3829-3833.
1982
Vikram A, Tripathi DN, Pawar AA, Ramarao P and Jena GB. Pre-bled-young-rats in genotoxicity testing: A model for peripheral blood micronucleus assay Regulatory Toxicology and Pharmacology 2008, 52, 147-157.
1983
Vikram A, Tripathi DN, Ramarao P and Jena GB. Intervention of d-glucose ameliorates the toxicity of streptozotocin in accessory sex organs of rat Toxicology and Applied Pharmacology 2008, 226, 84-93.
1984
Agarwal A, Deswal S, Hanspers K, Conklin BR, Garg P and Roy N. Creation and validation of S. pombe gene database for GenMAPP analysis International Journal of Integrative Biology 2007, 1, 113-117.
1985
Aher YD, Agarwal A, Bharatam PV and Garg P. 3D-QSAR studies of substituted 1-(3, 3-diphenylpropyl)-piperidinyl amides and ureas as CCR5 receptor antagonists Journal of Molecular Modeling 2007, 13, 519-529.
1986
Ankola D, Viswanad B, Bhardwaj V, Ramarao P and Ravi Kumar MNV. Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: Can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? European Journal of Pharmaceutics and Biopharmaceutics 2007, 67, 361-369.
1987
Balasinor N, Bhan A, Paradkar NS, Shaikh A, Nandedkar TD, Bhutani KK and Chaudhury MR. Postnatal development and reproductive performance of F1 progeny exposed in utero to an ayurvedic contraceptive: Pippaliyadi yoga Journal of Ethnopharmacology 2007, 109, 406-411.
1988
Banga S, Chawla G, Varandani D, Mehta BR and Bansal AK. Modification of the crystal habit of celecoxib for improved processability Journal of Pharmacy and Pharmacology 2007, 59, 29-39.
1989
Bansal SS, Kaushal AM and Bansal AK. Molecular and thermodynamic aspects of solubility advantage from solid dispersions Molecular Pharmaceutics 2007, 4, 794-802.
1990
1991
Bharate SB, Khan SI, Nafees AM Yunus, Siddheshwar K Chauthe, Jacob MR, Tekwani BL, Khan IA and Singh IP. Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols Bioorganic & Medicinal Chemistry 2007, 15, 87-96.
1992
Bhardwaj S, Shukla A, Mukherjee S, Sharma S, Guptasarma P, Chakraborti AK and Chakrabarti A. Putative structure and characteristics of a red water-soluble pigment secreted by Penicillium marneffei Medical Mycology 2007, 45, 419-427.
1993
1994
1995
Bhutani H, Singh S, Vir S, Bhutani KK, Kumar R, Chakraborti AK and Jindal KC. LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method Journal of Pharmaceutical and Biomedical Analysis 2007, 43, 1213-1220.
1996
Bisht B, Goel HL and Dey CS. Focal Adhesion Kinase regulates insulin resistance in skeletal muscle Diabetologia 2007, 50, 1058-1069.
1997
Bodiwala HS, Singh G, Singh R, Dey CS, Sharma SS, Bhutani KK and Singh IP. Antileishmanial amides and lignans from Piper cubeba and Piper retrofractum Journal of Natural Medicine 2007, 61, 418-421.
1998
Chakraborti AK, Rudrawar S, Jadhav KB, Kaur G and Chankeshwara SV. On Water organic synthesis: A highly efficient and clean synthesis of 2-aryl/heteroaryl/styryl benzothiazoles and 2-alkyl/aryl alkyl benzothiazolines Green Chemistry 2007, 9, 1335-1340.
1999
2000
Chawla G and Bansal AK. A comparative assessment of solubility advantage from glassy and crystalline forms of a water-insoluble drug European Journal of Pharmaceutical Sciences 2007, 32, 45-57.
2001
2002
Dessalew N and Bharatam PV. 3D-QSAR CoMFA Study on Aminothiazole Derivatives as Cyclin-Dependent Kinase 2 Inhibitors Molecular Informatics 2007, 26, 85-91.
2003
Dessalew N and Bharatam PV. Identification of potential glycogen kinase-3 inhibitors by structure based virtual screening Biophysical Chemistry 2007, 128, 165-175.
2004
Dessalew N and Bharatam PV. Structure based de novo design of novel glycogen synthase kinase 3 inhibitors Bioorganic & Medicinal Chemistry 2007, 15, 3728-3736.
2005
Dessalew N, Patel DS and Bharatam PV. 3D-QSAR and molecular docking studies on pyrazolopyrimidine derivatives as GSK3 inhibitors Journal of Molecular Graphics and Modelling 2007, 25, 885-895.
2006
Deswal S and Roy N. A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors European Journal of Medicinal Chemistry 2007, 42, 463-470.
2007
Eljarrat-Binstock E, Bentolila A, Kumar N, Harel H and Domb AJ. Preparation, characterization, and sterilization of hydrogel sponges for iontophoretic drug-delivery use Polymers for Advanced Technologies 2007, 18, 12-1.
2008
Fatima Y, Kansal H and Banerjee UC. Enantioselective reduction of aryl ketones using immobilized cells of Candida viswanathii Process Biochemistry 2007, 42, 1412-1418.
2009
2010
2011
Garg S, Jambu L and Vermani K. Development of novel sustained release bioadhesive vaginal tablets of povidone iodine Drug Development and Industrial Pharmacy 2007, 33, 1340-1349.
2012
Garkhal K, Verma S, Jonnalagadda S and Kumar N. Fast degradable poly(L-lactide-co-e-caprolactone) microsphere for tissue engineering: Synthesis, characterization and degradation behavior Journal of Polymer Science Part A: Polymer Chemistry 2007, 45, 2755-2764.
2013
Garkhal K, Verma S, Tikoo K and Kumar N. Surface modified poly (L-lactide-co-epsilon-caprolactone) microspheres as scaffold for tissue engineering Journal of Biomedical Materials Research 2007, A 82, 747-756.
2014
Gupta S. BVIMR Management Edge 2007, 1, (9) .
2015
Gupta S. GCU Journal of Business 2007, 2, (2) .
2016
Gupta S, Gupta YK and Sharma SS. Protective effect of pifithrin-alpha on brain ischemic reperfusion injury induced by bilateral common carotid arteries occlusion in gerbils Indian Journal of Physiology and Pharmacology 2007, 51, 62-68.
2017
Iqbal P, Patel D and Bharatam PV. Ab initio study on N N',N''-triaminoguanidine Journal of Physical Organic Chemistry 2007, 20, 1072-1080.
2018
Italia J, Bhatt D, Bhardwaj V, Tikoo K and Ravi Kumar MNV. PLGA nanoparticles for oral delivery of cyclosporine: Nephrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral Journal of Controlled Release 2007, 119, 197-206.
2019
Kadam RU, Chavan A and Roy N. Pharmacophoric features of P. aeruginosa deacetylase LpxC inhibitors: An electronic and structural analysis Bioorganic & Medicinal Chemistry Letters 2007, 17, 861-868.
2020
Kadam RU, Garg D, Chavan A and Roy N. Evaluation of Pseudomonas aeruginosa deacetylase LpxC inhibitory activity of dual PDE4-TNF α inhibitors: A multi-screening approach Journal of Chemical Information and Modeling 2007, 47, 1188-1195.
2021
Kadam RU, Garg D, Paul AT, Bhutani KK and Roy N. Evaluation of proinflammatory cytokine pathway inhibitors for p38 MAPK inhibitory potential Journal of Medicinal Chemistry 2007, 50, 6337-6342.
2022
Kadam RU, Shivange AV and Roy N. Escherichia coli versus Pseudomonas aeruginosa deacetylase LpxC inhibitors selectivity: surface and cavity-depth-based analysis Journal of Chemical Information and Modeling 2007, 47, 1215-1224.
2023
Kalra S, Jena GB, Tikoo K and Mukhopadhyay AK. Preferential inhibition of xanthine oxidase by 2-amino-6-hydroxy-8-mercaptopurine and 2-amino-6-purine thiol BMC Biochemistry 2007, 8, (8) .
2024
2025
Kashyap N, Viswanad B, Sharma G, Bhardwaj V, Ramarao P and Ravi Kumar MNV. Design and evaluation of biodegradable, biosensitive in situ gelling system for pulsatile delivery of insulin Biomaterials 2007, 28, 2051-2060.